Evolution of microbiological trends and treatment outcomes in peritoneal dialysis-related peritonitis

Clinical Nephrology

Volumn 75, Issue 5, 2011, Pages 416-425

  Huang, S T ^a   Chuang, Y W ^a   Cheng, C H ^a,b,e   Wu, M J ^a,d   Chen, C H ^a,c,f   Yu, T M ^c   Shu, K H ^a,b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e HUNGKUANG UNIVERSITY   (Taiwan)

^f TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

Morbidity; Mortality; Peritoneal dialysis; Peritonitis

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CEFTAZIDIME; GENTAMICIN; NEOMYCIN; PSEUDOMONIC ACID; VANCOMYCIN;

ADULT; ARTICLE; BACTERIAL PERITONITIS; CATHETER INFECTION; CATHETER REMOVAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PERITONEAL DIALYSIS; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME; TREATMENT RESPONSE; AGED; BACTERIUM; FUNGUS; ISOLATION AND PURIFICATION; KAPLAN MEIER METHOD; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PERITONITIS;

ADULT; AGED; BACTERIA; FEMALE; FUNGI; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONITIS; TREATMENT OUTCOME;

EID: 79958751052     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP75416     Document Type: Article

References (20)

1. Fried LD, Bernardini J, Johnson JR, Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol. 1996; 7: 2176-2182.
2. Choi P, Nemati E, Banerjee A, Preston E, Levy J, Brown E. Peritoneal dialysis catheter removal for acute peritonitis: a retrospective analysis of factors associated with catheter removal and prolonged postoperative hospitalization. Am J Kidney Dis. 2004; 43: 103-1011.
3. Davenport A. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, Peritonitis Audit 2002 - 2003. Perit Dial Int. 2009; 29: 297-302.
4. Zelenitsky S, Barns L, Findlay I, Alfa M, Ariano R, Fine A, MD, Harding G. Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis. 2000; 36: 1009-1013.
5. Kavanagh D, Prescott GJ, Mactier RA. Peritoneal dialysis-associated peritonitis in Scotland (1999 - 2002). Nephrol Dial Transplant. 2004; 19: 2584-2591.
6. Kim DK, Yoo TH, Ryu DR, Xu ZG, Kim HJ, Choi KH, Lee HY, Han DS, Kang SW. Changes in causative organisms and their antimicrobial susceptibilities inCAPDperitonitis: a single center's experience over one decade. Perit Dial Int. 2004; 24: 424-32.
7. Szeto CC, Leung CB, Chow KM, Kwan BC, Law MC, Wang AY, Lui SF, Li PK. Change in bacterial aetiology of peritoneal dialysis-related peritonitis over 10 years: experience from a centre in southeast Asia. ClinMicrobiol Infect. 2005; 11: 837-839.
8. Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int. 2006; 103 (Suppl.): 55-62.
9. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, Kuijper EJ, Li PK, Lye WC, Mujais S, Paterson DL, Fontan MP, Ramos A, Schaefer F, Uttley L. ISPD Ad Hoc Advisory Committee. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int. 2005; 25: 107-131.
10. Schaubel DE, Blake PD, Fenton SS. Effect of renal center characteristics on mortality and technique failure on peritoneal dialysis. Kidney Int. 2001; 60: 1517-1524.
11. Daly C, Campbell M, Cody J, Grant A, Donaldson C, Vale L, Lawrence P, MacLeod A, Wallace S, Khan I. Double bag or Y-set versus standard transfer system for continuous ambulatory peritoneal dialysis in end-stage renal disease. Cochrane Database Syst Rev. 2001; 2: CD003078.
12. Troidle L, Finkelstein F. Treatment and outcome of CPD-associated peritonitis. Ann Clin Microbiol Antimicrob. 2006; 5: 6.
13. Szeto CC, Kwan BC, Chow KM, Lau MF, Law MC, Chung KY, Leung CB, Li PK. Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases. Clin J Am Soc Nephrol. 2008; 3: 91-97.
14. Szeto CC, Chow KM, Kwan BC, Law MC, Chung KY, Yu S, Leung CB, Li PK. Staphylococcus aureus peritonitis complicates peritoneal dialysis: review of 245 consecutive cases. Clin J Am Soc Nephrol. 2007; 2: 245-251.
15. Piraino B, Bernardini J, Florio T, Fried L. Staphylococcus aureus prophylaxis and trends in gramnegative infections in peritoneal dialysis patients. Perit Dial Int. 2003; 23: 456-459.
16. Bunke CM, BrierME, Golper TA. Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 peritonitis study. Kid Int. 1997; 52: 524-529.
17. Valdes-Sotomayor J, Cirugeda A, Bajo MA, del Peso G, Escudero E, Sanchez-Tomero JA, Selgas R. Group de Estudios Peritoneales de Madrid. Increased severity of Escherichia coli peritonitis in peritoneal dialysis patients independent of changes in in vitro antimicrobial susceptibility testing. Perit Dial Int. 2003; 23: 450-455.
18. Szeto CC, Chow KM, Leung CB, Wong TY, Wu AK, Wang AY, Lui SF, Li PK. Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: Areview of 104 cases. Kidney Int. 2001; 59: 2309-2315.
19. Matuszkiewicz-Rowinska J. Update on fungal peritonitis and its treatment. Perit Dial Int. 2009; 29: 161-165.
20. Han SH, Lee SC, Ahn SV, Lee JE, Choi HY, Kim SW, Choi KH. Improving outcome of CAPD: twenty-five years' experience in a single Korean center. Perit Dial Int. 2007; 27: 432-440.